GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Earnings per Share (Diluted)

Biotage AB (Biotage AB) Earnings per Share (Diluted) : $0.30 (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Earnings per Share (Diluted)?

Biotage AB's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $0.04. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.30.

Biotage AB's EPS (Basic) for the three months ended in Mar. 2024 was $0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.30.

Biotage AB's EPS without NRI for the three months ended in Mar. 2024 was $0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $0.30.

During the past 12 months, Biotage AB's average EPS without NRIGrowth Rate was -13.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 10.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 6.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 18.50% per year.

During the past 13 years, Biotage AB's highest 3-Year average EPS without NRI Growth Rate was 51.00% per year. The lowest was -2.00% per year. And the median was 27.70% per year.


Biotage AB Earnings per Share (Diluted) Historical Data

The historical data trend for Biotage AB's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Earnings per Share (Diluted) Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.32 0.34 0.39 0.33

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 0.04 0.17 0.04

Competitive Comparison of Biotage AB's Earnings per Share (Diluted)

For the Medical Instruments & Supplies subindustry, Biotage AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's PE Ratio distribution charts can be found below:

* The bar in red indicates where Biotage AB's PE Ratio falls into.



Biotage AB Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Biotage AB's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(23.982-0)/73.994
=0.32

Biotage AB's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (Q: Mar. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(3.17-0)/80.064
=0.04

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Biotage AB  (OTCPK:BITGF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Biotage AB Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Biotage AB's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

Issue and re-purchase of class C shares for incentive program

By PRNewswire PRNewswire 11-30-2021

Biotage AB (publ) publishes new Financial Goals

By PRNewswire PRNewswire 03-14-2022

Biotage appoints Nomination Committee

By PRNewswire PRNewswire 09-24-2020

Biotage AB (publ) Interim Report January - March 2020

By PRNewswire PRNewswire 04-28-2020

Notice of Annual General Meeting in Biotage AB (publ)

By PRNewswire PRNewswire 04-28-2020

Biotage AB (publ) Interim report January - March 2021

By PRNewswire PRNewswire 04-28-2021